Alpa Laboratories Ltd Share Price

Q: What is the share price of Alpa Laboratories Ltd today?

Alpa Laboratories Ltd share price as on 12 Jun 2026 is ₹69.0

Pharmaceuticals

NSE: ALPA Small Cap ISIN: INE385I01010

As on 13 June 2026 at 02:40 IST

₹69

+ 1.92

(2.86%)

Sell Buy

Over 1 Month

-5.69%

Over 6 Months

-16.76%

Over 1 Year

-33.60%

Over 3 Years

3.12%

Alpa Laboratories Ltd Summary

Close ₹67.08

Open ₹68

High ₹68.74

Low ₹67

Volume 6,060

Net Turnover (in Cr) ₹0.04

52Wk High ₹108.30

52Wk Low ₹46.10

52Wk High / Low

46.10

108.30

Alpa Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹141.14

EPS (TTM) 7.11

Book Value (BV) 93.43

Div. Yield -

P/E (TTM) 9.56

Price/Book Value 0.73

Delivery % 68.12 %

Face Value 10

Key Ratios

PE Ratio 11.14

PB Ratio 1.20

EV to Sales 1.93

PEG Ratio 0.64

ROA 10.82

ROE 11.45

Debt-Equity 0.02

Net Profit Margin 17.50

Operating Profit Margin 25.18

Alpa Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	135.80	123.63	102.32	123.04	101.95
Total Expenses	110.13	102.95	86.43	103.48	91.16
Profit Before Tax	25.67	20.68	15.89	19.56	10.79
Profit After Tax	19.50	16.78	12.58	14.09	7.25
Operating Profit After Depreciation	25.90	21.04	16.11	19.78	10.86

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	20.65	11.47	7.04	9.32	7.21
Total Non Current Assets	30.14	21.39	18.14	17.23	19.29
Total Current Assets	192.49	160.98	149.13	138.01	121.08
Total Assets	222.63	182.37	167.27	155.24	140.37
Total Shareholder's Fund	171.43	151.91	134.58	121.73	107.64

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	18.32	3.65	8.90	9.94	-1.71
Net Cash Used In Investing Activities	-12.36	-13.34	2.13	-15.61	5.86
Net Cash Used In Financing Activities	-5.44	2.58	-3.79	5.44	0.19

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	135.76	123.61	102.36	123.06	101.96
Total Expenses	109.92	102.94	86.43	103.48	91.17
Profit Before Tax	25.84	20.67	15.93	19.58	10.79
Profit After Tax	19.68	16.78	12.62	14.13	7.26
Operating Profit After Depreciation	26.11	21.06	16.16	19.82	10.89

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	20.65	11.47	7.04	9.32	7.21
Total Non Current Assets	41.53	32.65	29.29	28.33	30.36
Total Current Assets	191.45	159.77	148.80	136.81	119.87
Total Assets	232.98	192.42	178.09	165.14	150.23
Total Shareholder's Fund	181.80	161.97	145.11	131.64	117.52

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	18.39	3.70	10.20	2.20	-1.47
Net Cash Used In Investing Activities	-12.49	-13.45	1.17	-15.61	5.82
Net Cash Used In Financing Activities	-5.48	2.26	-3.48	5.41	-0.03

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	31.40	29.05	26.26	19.11	39.92
Total Expenses	27.80	27.53	28.50	18.69	39.72
Profit Before Tax	3.07	1.75	0.12	11.76	2.08
Profit After Tax	1.38	1.59	0.11	11.77	-2.12
Operating Profit after Depreciation	3.44	2.43	0.82	12.36	2.68

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	31.40	29.67	25.63	19.11	39.11
Total Expenses	27.79	27.53	28.50	18.69	39.47
Profit Before Tax	3.05	1.72	0.10	11.78	2.25
Profit After Tax	1.36	1.87	0.10	11.78	-1.95
Operating Profit after Depreciation	3.43	2.40	0.82	12.38	2.88

Alpa Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 66.47

S2 65.87

S3 64.73

Pivot 67.61

R1 68.21

R2 69.35

R3 69.95

Moving Average

20 SMA 69.25

50 SMA 67.26

100 SMA 66.43

200 SMA 76.45

Alpa Laboratories Ltd Corporate Actions

No available data

Alpa Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Alpa Laboratories Ltd Top Mutal Funds Invested

No data available

Alpa Laboratories Ltd News

Alpa Laboratories to declare Quarterly Results

On 29 May 2026

13 May 2026, 10:53 am

Alpa Laboratories to declare Quarterly Results

On 11 February 2026

30 Jan 2026, 10:54 am

Alpa Laboratories schedules board meeting

On 14 November 2025

05 Nov 2025, 03:25 pm

Alpa Laboratories to conduct AGM

On 29 September 2025

15 Sep 2025, 10:44 am

Alpa Laboratories to conduct board meeting

On 13 August 2025

02 Aug 2025, 02:10 pm

Alpa Laboratories Ltd Stock Analysis

Annual revenue for Alpa Laboratories Ltd increased by 9.82% to ₹135.76 crore in FY 2025 from ₹123.61 crore in FY 2024.
Annual Net Profit for Alpa Laboratories Ltd increased by 17.29% to ₹19.68 crore in FY 2025 from ₹16.78 crore in FY 2024.
Promoter Shareholding in Alpa Laboratories Ltd decreased by 0.18% in the most recent quarter, from 57.29% in December 2025 to 57.19% in March 2026.
Alpa Laboratories Ltd delivered a 1-year return of -33.60% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Alpa Laboratories Ltd share price moved up by 2.86% from its previous close of INR ₹67.08. The latest Alpa Laboratories Ltd share price is INR ₹69.
Alpa Laboratories Ltd share price today has been at a low of 68.87 and a high of 69. Over the past 52 weeks, the Alpa Laboratories Ltd share price has seen a low of 46.10 and a high of 108.30.